Auro Pharmacies, Inc.

Form 483 issued November 5, 2015 · La Hab r a, California

Inspection
Sep 22 – Nov 5, 2015
Observations
9
Pages
8
FEI number
3011893599

In short: On November 5, 2015, FDA issued a Form 483 with 9 observations to Auro Pharmacies, Inc. in La Hab r a, California (FEI 3011893599) after an inspection that ran Sep 22 – Nov 5, 2015. The investigator was Uttaniti Limchumroon. Most observations concern laboratory controls and production; the most-cited regulation is 21 CFR 211.42 (design and construction features).

At a glance

Observations span 4 systems, led by laboratory controls.

Laboratory controls3
Production2
Facilities & equipment2
Materials1
Other1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Each batch of drug product purporting to be sterile and pyrogen-free is not laboratory tested to…

  2. 02

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not…

  3. 03

    Aseptic processing areas are deficient regarding the system…

  4. 04

    Laboratory controls do not include the establishment of scientifically sound and appropriate sampling plans and test…

5 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Auro Pharmacies, Inc.?

FDA listed 9 observations on this Form 483, mostly about laboratory controls, production and facilities & equipment. The most-cited regulation is 21 CFR 211.42 (design and construction features). The opening words of each observation are shown on this page.

Who inspected Auro Pharmacies, Inc.?

Uttaniti Limchumroon is named on this Form 483, for the inspection of Sep 22 – Nov 5, 2015. Each investigator has a profile showing what they cite most.

When was Auro Pharmacies, Inc. inspected by FDA?

The inspection ran Sep 22 – Nov 5, 2015, and the Form 483 is dated November 5, 2015.

How do I get the full Form 483 for Auro Pharmacies, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free